Standout Papers

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant... 2001 2026 2009 2017 578
  1. Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate (2001)
    Miljenko V. Pilepich, Kathryn Winter et al. International Journal of Radiation Oncology*Biology*Physics

Immediate Impact

4 from Science/Nature 77 standout
Sub-graph 1 of 19

Citing Papers

Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
2019 Standout
2 intermediate papers

Works of Madhu J. John being referenced

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group
1995
Phase II trial of hormonal cytoreduction with megestrol and diethylstilbestrol in conjunction with radiotherapy for carcinoma of the prostate: Outcome results of RTOG 83-07
1995

Author Peers

Author Last Decade Papers Cites
Madhu J. John 1105 1714 329 372 44 2.3k
Kiyoshi Ohara 613 1141 273 687 52 1.9k
Weining Zhen 863 906 547 304 66 2.6k
Louke Delrue 464 1562 493 392 50 2.2k
D. Cowen 741 899 491 328 75 2.3k
Steve P. Lee 686 973 829 368 72 2.6k
Peter H. Blitzer 1190 1163 881 546 42 2.6k
J.B. Dubois 599 2985 534 752 38 3.5k
Omar M. Salazar 689 1159 617 265 84 2.5k
S. Hoffstetter 901 468 557 163 80 1.8k
Howard S. Levin 1398 1975 361 220 89 3.4k

All Works

Loading papers...

Rankless by CCL
2026